Corvus Pharmaceuticals to Present Preclinical and Early Clinical Data from the Phase 1/1b Trial with CPI-818 at the American Society of Hematology (ASH) Annual Meeting

    NEXT STORY
    electroCore to Announce Third Quarter 2019 Financial Results on Wednesday, November 13th
    PREV STORY
    Surface Oncology Presents Updates at the Society for Immunotherapy of Cancer’s Annual Meeting
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Predictive Oncology Has Regained Compliance with Nasdaq’s Minimum Bid Price Requirement

    author_avatar
    NASDAQ Market News

    Aptevo Therapeutics to Present at the 30th Annual ROTH Conference

    SEATTLE, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq:APVO), a biotechnology company ...

    author_avatar
    NASDAQ Market News

    Merus Provides Clinical Updates for MCLA-117 and MCLA-158 Programs

    - IND submitted to U.S. FDA for MCLA-117 in AML - - First CTA ...

    author_avatar
    NASDAQ Market News